Increasing numbers of transgender adolescents are presenting for transition-related medical care, including gender-affirming estrogen and testosterone. The decision to transition with hormones has long-term implications, including possible irreversible impairment of future reproductive functioning. The commentary by Hudson, Nahata, Dietz, and Quinn (2018) outlines the importance of fertility counseling for transgender adolescents and young adults as ethical, interdisciplinary practice. Key considerations raised include implementing shared decision-making strategies that account for youths’ maturity and individual decisional capacity, evaluating co-occurring psychiatric conditions that could interfere with future-oriented decision-making, and considering benefits and harms of fertility preservation (FP) in the context of a youth’s values, identity, and comfort. This report includes two case illustrations of transmasculine youth which highlight how ethical considerations emerge in clinical practice and underscore the nuance and complexity of fertility-related decision-making among transgender adolescents.
Get full access to this article
View all access options for this article.
References
1.
American Academy of Pediatrics Committee on Bioethics. (1995). Informed consent, parental permission, and assent in pediatric practice. Pediatrics, 95, 314–317.
2.
Campo-EngelsteinL.ChenD. (2016). Ethical issues in pediatric and adolescent fertility preservation. In WoodruffT. K.& GosiengfiaoY. C. (Eds.), Pediatric and adolescent oncofertility. Amsterdam, the Netherlands: Springer.
3.
ChenD.HidalgoM. A.LeibowitzS.LeiningerJ.SimonsL. K.FinlaysonC.GarofaloR. (2016). Multidisciplinary care for gender-diverse youth: A narrative review and unique model of gender-affirming care. Transgender Health, 1, 117–123.
4.
ChenD.SimonsL.JohnsonE. K.LockartB. A.FinlaysonC. (2017). Fertility preservation for transgender adolescents. The Journal of Adolescent Health, 61, 120–123. 10.1016/j.jadohealth.2017.01.022
5.
ChenM.FuquaJ.EugsterE. A. (2016). Characteristics of referrals for gender dysphoria over a 13-year period. Journal of Adolescent Health, 58, 369–371. 10.1016/j.jadohealth.2015.11.010
6.
ColemanE.BocktingW.BotzerM.Cohen-KettenisP.DeCuypereG.FeldmanJ.. . .ZuckerK. (2012). Standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. International Journal of Transgenderism, 13, 165–232. 10.1080/15532739.2011.700873
7.
CostaR.ColizziM. (2016). The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: A systematic review. Neuropsychiatric Disease and Treatment, 12, 1953–1966. 10.2147/NDT.S95310
8.
De SutterP. (2001). Gender reassignment and assisted reproduction: Present and future reproductive options for transsexual people. Human Reproduction, 16, 612–614. 10.1093/humrep/16.4.612
9.
De SutterP.KiraK.VerschoorA.HotimskyA. (2002). The desire to have children and the preservation of fertility in transsexual women: A survey. International Journal of Transgenderism, 6, 215–221.
10.
DevineK.MumfordS. L.GoldmanK. N.Hodes-WertzB.DruckenmillerS.PropstA. M.NoyesN. (2015). Baby budgeting: Oocyte cryopreservation in women delaying reproduction can reduce cost per live birth. Fertility and Sterility, 103, 1446–1453.e2. 10.1016/j.fertnstert.2015.02.029
11.
ElbogenE. B.SwansonJ. W.AppelbaumP. S.SwartzM. S.FerronJ.Van DornR. A.WagnerH. R. (2007). Competence to complete psychiatric advance directives: Effects of facilitated decision making. Law and Human Behavior, 31, 275–289. 10.1007/s10979-006-9064-6
12.
HembreeW. C.Cohen-KettenisP. T.GoorenL.HannemaS. E.MeyerW. J.MuradM. H.. . .T’SjoenG. G. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 102, 3869–3903. 10.1210/jc.2017-01658
13.
HermanJ. L.HaasA. P.RodgersP. L. (2014). Suicide attempts among transgender and gender non-conforming adults (pp. 1–18). Los Angeles, CA: Williams Institute.
14.
HudsonJ.NahataL.DietzE.QuinnG. P. (2018). Fertility counseling for transgender AYAs. Clinical Practice in Pediatric Psychology, 6, 84–92. 10.1037/cpp0000180
15.
IkedaK.BabaT.NoguchiH.NagasawaK.EndoT.KiyaT.SaitoT. (2013). Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Human Reproduction, 28, 453–461. 10.1093/humrep/des385
16.
LightA. D.Obedin-MaliverJ.SeveliusJ. M.KernsJ. L. (2014). Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstetrics and Gynecology, 124, 1120–1127. 10.1097/AOG.0000000000000540
17.
MaxwellS.NoyesN.KeefeD.BerkeleyA. S.GoldmanK. N. (2017). Pregnancy outcomes after fertility preservation in transgender men. Obstetrics and Gynecology, 129, 1031–1034. 10.1097/AOG.0000000000002036
18.
RuheK. M.WangmoT.BadarauD. O.ElgerB. S.NiggliF. (2015). Decision-making capacity of children and adolescents—Suggestions for advancing the concept’s implementation in pediatric healthcare. European Journal of Pediatrics, 174, 775–782. 10.1007/s00431-014-2462-8
19.
SchulzeC. (1988). Response of the human testis to long-term estrogen treatment: Morphology of Sertoli cells, Leydig cells and spermatogonial stem cells. Cell and Tissue Research, 251, 31–43. 10.1007/BF00215444
WahlertL.FiesterA. (2013). A false sense of security: Lesbian, gay, bisexual, and transgender (LGBT) surrogate health care decision-making rights. Journal of the American Board of Family Medicine, 26, 802–804. 10.3122/jabfm.2013.06.130130
22.
WallaceS. A.BloughK. L.KondapalliL. A. (2014). Fertility preservation in the transgender patient: Expanding oncofertility care beyond cancer. Gynecological Endocrinology, 30, 868–871. 10.3109/09513590.2014.920005
23.
WierckxK.Van CaenegemE.PenningsG.ElautE.DedeckerD.Van de PeerF.. . .T’SjoenG. (2012). Reproductive wish in transsexual men. Human Reproduction, 27, 483–487. 10.1093/humrep/der406
